GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Pre-Tax Income

Immunocore Holdings (Immunocore Holdings) Pre-Tax Income : $-86.8 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Immunocore Holdings's pretax income for the three months ended in Mar. 2024 was $-30.6 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-86.8 Mil. Immunocore Holdings's pretax margin was -34.15%.

During the past 6 years, Immunocore Holdings's highest Pretax Margin was -23.45%. The lowest was -493.03%. And the median was -331.44%.


Immunocore Holdings Pre-Tax Income Historical Data

The historical data trend for Immunocore Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Pre-Tax Income Chart

Immunocore Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial -165.39 -117.42 -239.20 -49.80 -77.08

Immunocore Holdings Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.25 -17.58 2.18 -40.84 -30.60

Competitive Comparison of Immunocore Holdings's Pre-Tax Income

For the Biotechnology subindustry, Immunocore Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunocore Holdings's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunocore Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Immunocore Holdings's Pre-Tax Income falls into.



Immunocore Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Immunocore Holdings's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-75.505+-17.814+-6.524+22.767+0
=-77.1

Immunocore Holdings's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-33.659+-3.299+-4.116+10.478+-3.5527136788005E-15
=-30.6

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-86.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immunocore Holdings  (NAS:IMCR) Pre-Tax Income Explanation

Immunocore Holdings's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-30.596/89.583
=-34.15%

During the past 6 years, Immunocore Holdings's highest Pretax Margin was -23.45%. The lowest was -493.03%. And the median was -331.44%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immunocore Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunocore Holdings (Immunocore Holdings) Business Description

Traded in Other Exchanges
Address
92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.